Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate [Phase 2]
Phase 2 clinical trial update for enzalutamide with leuprolide ± abiraterone/pred in prostate cancer; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2019-10-07Clinical Trial Update: Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer [Phase 3]
Phase 3 trial update for fluciclovine (18F) PET/CT in biochemical recurrence of prostate cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: Safety and Efficacy Study of Dose-escalated Hypofractionated Radiotherapy For Prostate Cancer [Phase 1, Phase 2]
A dose-escalated hypofractionated radiotherapy trial for prostate cancer completed phases 1 and 2 to assess safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2019-10-03Clinical Trial Update: A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer [Phase 1]
Phase 1 trial update for MDV3100 (enzalutamide) in patients with castration-resistant (hormone-refractory) prostate cancer; study completed …
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases [Phase 2]
Phase 2 trial evaluating denosumab plus enzalutamide with or without abiraterone and prednisone in men with castration-resistant prostate ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-24Clinical Trial Update: Analyze the Predictive Value of Gene TMPRSS2-ETS in Response to Enzalutamide in Patients With Prostate Cancer [Phase 2]
Phase 2 trial assessing whether TMPRSS2-ETS gene status predicts response to enzalutamide in hormone-refractory prostate cancer.
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: Firmagon (Degarelix) Intermittent Therapy [Phase 4]
Phase 4 trial update for Degarelix (Firmagon) intermittent therapy in recurrent prostate cancer; study terminated.
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Eradication of Prostate Cancer Using F-989 [Phase 2]
Phase 2 clinical trial evaluating F-989 for eradication of prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-18Clinical Trial Update: Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery [Phase 3]
Phase 3 trial assessing robot-assisted radical prostatectomy and its effect on short-term continence recovery after surgery.
-
CLINICAL_TRIALS trial_result · 2019-09-18Clinical Trial Update: High-Dose Stereotactic Radiation for Prostate Cancer [NA]
A completed clinical trial evaluating high-dose stereotactic radiation for prostate cancer with results posted in 2019.
-
FDA approval · 2019-09-17FDA Approved: ERLEADA — Supplemental Application (Janssen Products, LP)
The FDA approved a supplemental application for ERLEADA (apalutamide) submitted by Janssen Products, LP.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Fusion Targeted Biopsy of the Prostate [NA]
Completed clinical trial on fusion-targeted biopsy for prostate cancer; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer [Phase 1]
Phase I trial evaluating intensity modulated radiation therapy for prostate cancer; study terminated with results posted.
-
CLINICAL_TRIALS research · 2019-09-11Clinical Trial Update: Pharmacoeconomics and Related Patient Outcomes of Multi-dose Intravenous Acetaminophen (OFIRMEV) [Phase 4]
A Phase 4 pharmacoeconomics study evaluating multi-dose intravenous acetaminophen (OFIRMEV) and patient outcomes following prostatectomy.
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: TKI258 in Castrate Resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial update for TKI258 in castration-resistant prostate cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: Miami Membrane for Potency (MMEP) Trial [Phase 2]
Phase 2 trial of Miami Membrane for Potency (MMEP) in prostate cancer was terminated; results posted in 2019.
-
FDA approval · 2019-09-05FDA Approved: DOCETAXEL — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for docetaxel (docetaxel anhydrous) by Mylan Institutional LLC under ANDA 210072.
-
CLINICAL_TRIALS research · 2019-08-28Clinical Trial Update: Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers [Phase 2]
Phase 2 trial evaluating ferumoxytol-enhanced MRI for detecting lymph node metastases in prostate, bladder, and kidney cancers; study comple…
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer [NA]
Clinical trial update for stereotactic radiation therapy in prostate cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy [Phase 1, Phase 2]
Phase 1/2 trial evaluating temsirolimus with bevacizumab in hormone-resistant metastatic prostate cancer that failed chemotherapy has comple…
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases [Phase 2, Phase 3]
A phase 2/3 trial comparing conventional care to radioablation (stereotactic body radiotherapy) for extracranial oligometastases; status is …
-
CLINICAL_TRIALS trial_result · 2019-08-19Clinical Trial Update: Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T
Clinical trial update detailing immune monitoring protocol for men with prostate cancer in a sipuleucel-T study; trial status terminated wit…
-
CLINICAL_TRIALS trial_result · 2019-08-15Clinical Trial Update: TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer [Phase 2]
Phase II trial update for Olaparib (TOPARP) in advanced castration-resistant prostate cancer.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating metformin hydrochloride as first-line therapy for locally advanced or metastatic prostate cancer has compl…
-
CLINICAL_TRIALS trial_result · 2019-08-09Clinical Trial Update: Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer [Phase 2]
Phase 2 clinical trial investigating everolimus as first-line therapy for prostate cancer has completed.